Two Norwegian scientists have discovered a new molecule which could greatly reduce two of the biggest challenges in today’s health care: Cancer and multi-resistant bacteria. The Lytix-peptide derived from colostrum has a lofty potential, and hopefully human testing will soon confirm the initial results.

Read the full story